APTALIS PHARMA LIMITED

BIORISE

PHARMACEUTICAL PREPARATIONS, NAMELY, A DRUG DELIVERY SYSTEM COMPRISING TABLETS, CAPSULES, AND POWDERS THAT PROVIDE FOR ENHANCED BIOAVAILABILITY OF A WIDE VARIETY OF POORLY SOLUBLE PHARMACEUTICALS;The wording biorise has no meaning in a foreign language.;

DIFFUSPHERES

Manufacture and formulation of pharmaceutical substances to the requirements of others, namely, treatment of pharmaceutical substances into controlled release microtablets and capsules;Pharmaceutical preparations and substances for the treatment of gastrointestinal disorders, central nervous system disorders, cardiovascular disorders, diseases of the muscular skeletal system and infectious diseases in the form of controlled release tablets or capsules for prolonged or delayed action; dietetic substances in the nature of dietary supplements adapted for medical use;DIFFUSE SPHERES;Color is not claimed as a feature of the mark.;Research and development of oral drug delivery formulations used as facilitating agents for pharmaceuticals compounds, vitamins, foods supplements, and veterinary preparations;

PRECISELY THE WAY IT SHOULD BE

Pharmaceutical preparations for treatment of gastrointestinal disorders;

PRECISELY THE WAY IT SHOULD BE

Educational services, providing live and on-line programs and presentations to promote the awareness of gastrointestinal disorders, the related healthcare consequences of gastrointestinal disorders, treatment options and regimens for gastrointestinal disorders, and printable materials distributed therewith;Printed materials, namely, pamphlets and brochures directed to medical personnel and consumers on gastrointestinal disorders and the treatment thereof;

ZAC

Providing information and assistance to patients via telephone or the internet with regard to health insurance coverage, reimbursement and insurance claims processing for pharmaceuticals;

ZPOINTS

Z POINTS;Promoting the treatment of cystic fibrosis by means of arranging and conducting incentive reward programs that rewards patient compliance with physician recommended treatment programs;